Simply Managing Complex Data
The HIV genotypic drug resistance algorithm within SmartGene for Stanford HIVDB has been updated.
The reference sequences available in SmartGene's Influenza module have been updated.
Promega's workflow solutions for sample extraction through sequencing, together with SmartGene's convenient and action-oriented analysis Apps, offer an accessible alternative to outsourcing sequence-based identification of organisms. SmartGene's Web Apps guide the user from .ab1 files to final report generation, requiring no local hardware, specific software, nor bioinformatics staff. A new White Paper is now available, A Sample-to-Action Solution for Microbial identification: Sequencing on the [Promega] Spectrum Compact CE System with SmartGene Analysis.
Reliable and reproducible microbiome testing in clinical practice requires standardization of methods and comprehensive, representative, up-to-date reference databases. In a new article published in PLOS One, read how SmartGene's BiomeScan Apps for Microbiome analysis and SmartGene's proprietary Centroid reference databases can meet these needs.
For a summary, click here to go to SmartGene's Scientific Publications Section for Microbiology on this website.
We are closely following the epidemiology of the SARS-CoV-2 variants in order to update our reference database, the SARS-CoV-2 Variant Typing Dataset (in our Coronavirus App).
We have updated our reference database, the SARS-CoV-2 Variant Typing Dataset.
As a part of the continuous enhancement of our Services, we released a new version of our ASP Platform (IDNS® 5 v3.11.0). A new version of our NGS pipelines (v2.6.0) also comes with this release.
Version 33 of the ANRS HIV-1 algorithm has been implemented on the SmartGene IDNS® Service platforms.
SmartGene and Illumina announce their collaboration to promote broad adoption of next generation sequencing for routine testing.
SmartGene announces a new collaboration with The Johns Hopkins University clinical microbiology division to study various sequencing technologies for bacterial and fungal identification.
SmartGene, headquartered in Switzerland, has a new address.
The SmartGene Bacteria 16S module continues to grow to cover more species.
A new version of the SmartGene NGS Coronavirus Analysis Pipeline has been implemented.
SmartGene services to be used for the local detection of SARS-CoV-2 variants and national surveillance across France.
SmartGene's Bacteria Module is the perfect complement to the Applied Biosystems SeqStudio™ Genetic Analyzer.
Genetic analyses of SARS-CoV-2 and other Coronaviridae will have an increasingly important role to play, both in the current fight against COVID-19 and in preventing future epidemics of Coronaviridae.
SmartGene announces a clinical research collaboration with France's Centre of Excellence for the study and treatment of hepatitis viruses at the Virology Laboratory and National Reference Center for Viral Hepatitis B, C, and delta at Hospital Henri Mondor, University Paris-Est, Paris, France.
The IDNS Fungi 25-28S Reference Database has been reconfigured to improve coverage and species representation.
SmartGene receives certification of compatibility regarding the requirements of Title 21 Part 11 of the US Code of Federal Regulations.
Professor Anne-Geneviève Marcelin of Pitié-Salpêtrière Hospital Sorbonne, Paris, France presented the findings of a study based on data collected and analyzed using tools and search algorithms which SmartGene has made available for this purpose: Epidemiological study of Doravirine associated resistance mutations in HIV-1-infected treatment-naïve patients from two large databases in France and Italy.
With the release of version 5.3, SmartGene has applications available for HIV, Microbiome 16S, and HCV.
Following a successful notification to Swissmedic, the Swiss Agency for Therapeutic Products, SmartGene announces that the SmartGene Service Modules for HIV, HCV, Bacteria, Fungi, and HLA have obtained CE-IVD labeling.
Order by Supreme Court of the United States confirms SmartGene’s success invalidating patents which threatened the practice of personalized medicine.
Poster presented at the Medical Biodefense Conference in Munich, Germany.
SmartGene becomes an official Service Provider to the Public Hospital Laboratories AP-HP in Paris, France.
SmartGene Inc. announces the availability of curated reference databases to aid in sequence-based identification of Nocardia species.
SmartGene and the Institute of Medical Microbiology, University of Zurich expand their collaboration to address the sequence-based validation of mass spectrometry platforms for clinical microbiology.
SmartGene's Services for faster, more precise identification of Bacteria and Fungi to be used by the Johns Hopkins Hospital.
SmartGene has recently signed a contract to develop a data-analysis and data-management system dedicated to the typing of Campylobacter species as part of a European Union Consortium project called BIOTRACER.
SmartGene Inc. and LabCorp enter into a collaboration for faster, more precise identification of Bacteria and Fungi by sequence analysis.